鳥居薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/12/07 | 2,774 | 2,810 | 2,772 | 2,806 | +35 | +1.3% | 17,500 |
2022/12/06 | 2,810 | 2,824 | 2,771 | 2,771 | -39 | -1.4% | 19,500 |
2022/12/05 | 2,844 | 2,844 | 2,779 | 2,810 | -18 | -0.6% | 36,300 |
2022/12/02 | 2,882 | 2,882 | 2,818 | 2,828 | -44 | -1.5% | 48,900 |
2022/12/01 | 2,902 | 2,917 | 2,864 | 2,872 | -30 | -1% | 28,900 |
2022/11/30 | 2,925 | 2,925 | 2,895 | 2,902 | -19 | -0.7% | 48,600 |
2022/11/29 | 2,915 | 2,935 | 2,885 | 2,921 | -1 | ±0% | 24,300 |
2022/11/28 | 2,952 | 2,958 | 2,922 | 2,922 | -44 | -1.5% | 11,300 |
2022/11/25 | 2,974 | 2,993 | 2,958 | 2,966 | -11 | -0.4% | 26,500 |
2022/11/24 | 2,991 | 3,000 | 2,970 | 2,977 | -13 | -0.4% | 27,700 |
2022/11/22 | 2,960 | 2,995 | 2,960 | 2,990 | +40 | +1.4% | 46,700 |
2022/11/21 | 2,931 | 2,965 | 2,921 | 2,950 | +19 | +0.6% | 27,000 |
2022/11/18 | 2,915 | 2,945 | 2,915 | 2,931 | +23 | +0.8% | 27,500 |
2022/11/17 | 2,875 | 2,929 | 2,875 | 2,908 | +13 | +0.4% | 15,200 |
2022/11/16 | 2,898 | 2,902 | 2,871 | 2,895 | -7 | -0.2% | 23,100 |
2022/11/15 | 2,896 | 2,924 | 2,896 | 2,902 | +6 | +0.2% | 20,300 |
2022/11/14 | 2,890 | 2,900 | 2,881 | 2,896 | -16 | -0.5% | 13,100 |
2022/11/11 | 2,929 | 2,929 | 2,886 | 2,912 | +31 | +1.1% | 18,800 |
2022/11/10 | 2,907 | 2,907 | 2,873 | 2,881 | -20 | -0.7% | 20,300 |
2022/11/09 | 2,900 | 2,914 | 2,888 | 2,901 | -3 | -0.1% | 20,600 |
2022/11/08 | 2,894 | 2,929 | 2,884 | 2,904 | -1 | ±0% | 22,000 |
2022/11/07 | 2,901 | 2,923 | 2,875 | 2,905 | +7 | +0.2% | 14,300 |
2022/11/04 | 2,919 | 2,919 | 2,880 | 2,898 | -62 | -2.1% | 32,600 |
2022/11/02 | 2,961 | 2,986 | 2,921 | 2,960 | +29 | +1% | 31,500 |
2022/11/01 | 3,000 | 3,000 | 2,850 | 2,931 | -89 | -2.9% | 49,000 |
2022/10/31 | 3,020 | 3,055 | 3,000 | 3,020 | +49 | +1.6% | 54,200 |
2022/10/28 | 2,979 | 3,010 | 2,961 | 2,971 | -49 | -1.6% | 92,900 |
2022/10/27 | 3,010 | 3,020 | 2,993 | 3,020 | +20 | +0.7% | 25,800 |
2022/10/26 | 2,950 | 3,015 | 2,950 | 3,000 | +63 | +2.1% | 38,700 |
2022/10/25 | 2,957 | 2,962 | 2,931 | 2,937 | +16 | +0.5% | 31,900 |
2022/10/24 | 2,972 | 2,988 | 2,921 | 2,921 | -17 | -0.6% | 39,000 |
2022/10/21 | 2,949 | 2,953 | 2,927 | 2,938 | -11 | -0.4% | 17,900 |
2022/10/20 | 2,935 | 2,973 | 2,935 | 2,949 | -24 | -0.8% | 18,100 |
2022/10/19 | 2,975 | 3,005 | 2,966 | 2,973 | +10 | +0.3% | 26,000 |
2022/10/18 | 2,976 | 2,979 | 2,948 | 2,963 | +37 | +1.3% | 28,100 |
2022/10/17 | 2,916 | 2,942 | 2,916 | 2,926 | -33 | -1.1% | 15,600 |
2022/10/14 | 2,959 | 2,977 | 2,941 | 2,959 | +31 | +1.1% | 36,100 |
2022/10/13 | 2,940 | 2,944 | 2,915 | 2,928 | -22 | -0.7% | 21,100 |
2022/10/12 | 2,940 | 2,973 | 2,925 | 2,950 | +3 | +0.1% | 39,400 |
2022/10/11 | 2,923 | 2,963 | 2,919 | 2,947 | -8 | -0.3% | 31,200 |
2022/10/07 | 2,917 | 2,960 | 2,915 | 2,955 | -5 | -0.2% | 27,700 |
2022/10/06 | 2,920 | 2,968 | 2,920 | 2,960 | +40 | +1.4% | 38,200 |
2022/10/05 | 2,946 | 2,946 | 2,920 | 2,920 | -5 | -0.2% | 25,600 |
2022/10/04 | 2,903 | 2,937 | 2,903 | 2,925 | +31 | +1.1% | 34,300 |
2022/10/03 | 2,834 | 2,895 | 2,815 | 2,894 | +10 | +0.3% | 44,000 |
2022/09/30 | 2,895 | 2,914 | 2,879 | 2,884 | +27 | +0.9% | 51,900 |
2022/09/29 | 2,806 | 2,859 | 2,806 | 2,857 | +111 | +4% | 44,500 |
2022/09/28 | 2,700 | 2,751 | 2,691 | 2,746 | +30 | +1.1% | 56,400 |
2022/09/27 | 2,743 | 2,758 | 2,712 | 2,716 | -16 | -0.6% | 30,300 |
2022/09/26 | 2,728 | 2,755 | 2,726 | 2,732 | -29 | -1.1% | 30,600 |
601~
650
件表示中 / 3704件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
サワイGHD | 189,200円 | +5.9% | +24.5% | 2.91% | 12.56倍 | 1.18倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
キッセイ薬 | 387,000円 | +3.6% | +6.1% | 3.10% | 13.04倍 | 0.77倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
科研薬 | 373,800円 | -6.4% | -71.8% | 5.08% | 41.63倍 | 0.93倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 300,500円 | +7.9% | -3.3% | 2.66% | 8.36倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム